翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 中國飛鶴有限公司 呈交日期： 2025年12月18日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 FF305 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06186 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

Group 1 - The Hong Kong consumer sector experienced slight fluctuations, with the Hong Kong Consumer ETF (513230) showing a minor decline of approximately 0.5% [1] - Key stocks that performed well include Zhenjiu Lidu, Xtep International, Master Kong Holdings, Uni-President China, and China Feihe, while stocks like Xiaocaiyuan, Miniso, KANAT Optical, and Jingyuan International saw significant declines [1] - The Central Economic Work Conference highlighted the prominent contradiction of strong supply and weak demand domestically, emphasizing the expansion of domestic demand as a top priority for China's economic work in 2026 [1] Group 2 - The Ministry of Commerce, the People's Bank of China, and the National Financial Regulatory Administration issued a notice on December 14, proposing 11 policy measures to enhance collaboration between commerce and finance to boost consumption across various sectors [1] - Tianfeng Securities believes that the consumer sector's valuation has reached a relatively low level, suggesting a reduced expectation for policy changes and a need to focus on new consumption driven by domestic demand [1] - Related popular ETFs include the Tourism ETF (562510) benefiting from holiday catalysts and the Ice and Snow Economy, the Food and Beverage ETF (515170) focusing on boosting domestic demand, and the Hong Kong Consumer ETF (513230) linked to e-commerce leaders and new consumption trends [2]

Core Viewpoint - The food and beverage industry is experiencing a new normal with a weak overall consumption environment, emphasizing high quality-price ratios, functionality, health, and emotional consumption trends. The liquor industry continues to face weak demand, while snacks and beverages show better performance. The industry is expected to maintain a weak recovery with strong differentiation, relying on product innovation, fragmented channel layouts, and expanding consumer demographics [2][3][10]. Liquor Industry - The liquor industry is undergoing significant adjustments due to weak demand and new regulations, with expectations for a turning point in the first half of 2026 as the supply-demand balance improves. The impact of policies on demand is expected to weaken, leading to a gradual recovery in consumption [6][7]. - The strategic focus of liquor companies has shifted from inventory pressure to exploring new growth areas, such as targeting younger consumers and embracing new retail channels. This shift is expected to lead to a clearer upward trend in financial reports by 2026 [8][9]. - High-end liquor is anticipated to lead the overall recovery, benefiting from brand loyalty and the resumption of business activities. The mid-range segment may face challenges but is also expected to see some recovery [9]. Snack and Beverage Industry - The overall demand for snacks is stabilizing at a low level, with a focus on quality-price ratios and emotional value. The snack industry is expected to continue expanding, particularly in channels like bulk snacks and membership supermarkets [11][12]. - The beverage industry is benefiting from health trends, with a notable increase in demand for low-sugar and functional drinks. The market for instant retail is also growing, with significant sales increases in snack brands through platforms like Meituan [21][22]. - The competition in the beverage sector is expected to remain intense, but price competition is easing, allowing for improved profit margins for leading companies [22][23]. Dairy and Frozen Food Industry - The dairy industry is experiencing a recovery in operational performance, with expectations for improved profitability as raw milk prices stabilize. The demand for liquid milk is projected to stabilize in 2026, with a potential turning point in the raw milk supply-demand balance [33][34][37]. - The frozen food industry is facing pressure from weak demand but is seeing a stabilization in competition. Companies are focusing on product innovation and new channel development to improve profitability [42][43]. Condiments and Health Products - The condiment industry is expected to see stable demand in 2025, with a focus on product upgrades and innovation from leading companies. The overall competitive landscape is anticipated to become less aggressive as inventory levels normalize [44][48]. - The health product sector is experiencing a shift towards online sales and long-tail brand growth. Leading brands are expected to stabilize their market share through channel expansion and product diversification [55][56].

Core Viewpoint - China Feihe (06186) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Share Buyback Details - The company plans to repurchase 2.945 million shares at a total cost of HKD 11.8689 million [1] - The buyback price per share is set between HKD 4.02 and HKD 4.04 [1]

Group 1 - The company China Feihe (06186.HK) announced a share buyback plan, intending to repurchase 2.945 million shares at a total cost of HKD 11.8689 million [1] - The buyback price per share is set between HKD 4.02 and HKD 4.04 [1]

智通财经APP讯，中国飞鹤(06186)发布公告，于2025年12月17日，该公司斥资1186.89万港元回购294.5 万股股份，每股回购价格为4.02-4.04港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 中國飛鶴有限公司 呈交日期： 2025年12月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06186 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 China Feihe Limited 中國飛鶴有限公司 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：6186） 須予披露交易 認購金融產品 認購金融產品 茲提述本公司日期為二零二四年十二月三十日及二零二五年九月二十四日的 公 告，內 容 有 關（其 中 包 括）本集團認購若干中信銀行的理財及結構性存款金融 產 品（「認購中信銀行金融產品」）。 董 事 會 宣 佈，於 二 零 二 五 年 十 二 月 十 六 日，本 公 司 全 資 附 屬 公 司 黑 龍 江 飛 鶴 銷 售以其閑置資金認購若干中信銀行發售的金額為人民幣700百萬元的理財金融 產 品（「認購信銀產品」）。下 表 載 列 認 購 信 銀 產 品 之 主 要 條 款： 所認購 預 期 本金金額 年收益率 | （人 民 幣 元） 產品名稱 到期日 | | ...

Core Viewpoint - The report from Feihe highlights a strong financial performance and a confident outlook for future growth, driven by its core strategy of "a new generation more suitable for Chinese babies" [2][3] Financial Performance - Feihe reported a revenue of 9.15 billion and a net profit of 1.03 billion for the first half of 2025, with cash and cash equivalents amounting to 6.48 billion, providing a solid foundation for strategic actions [2] - The company announced a share buyback plan of no less than 1 billion and an annual dividend plan totaling approximately 2 billion, reflecting management's confidence in cash flow health and optimistic future profitability [2] Strategic Initiatives - Feihe's "new generation more suitable" strategy is a comprehensive evolution focused on "fresh nutrition," addressing the upgraded consumer demand where 78% of educated mothers prioritize "active nutrition" and "good absorption" when selecting formula [3][5] - The introduction of high-end products, such as Jicui and Qicui, exemplifies this strategy, with a focus on self-researched and produced key raw materials, reducing the freshness timeline from years to within 30 days [3][5] Technological Advancements - Feihe achieved a significant technological leap with a proven 6.4 times better absorption rate and is the first in the industry to implement "raw material traceability," enhancing consumer trust through verifiable scientific data [5][7] - The company adheres to a "clinical first, market later" approach, establishing a competitive barrier through rigorous clinical trials, with products demonstrating superior performance in key immune indicators and cognitive development metrics [5][7] Market Position and Global Strategy - Feihe holds leading positions in several key metrics, including first in Chinese breast milk research and infant formula patents, which underpin its premium product matrix and market pricing power [7] - The company is expanding its global footprint, with a Canadian factory receiving the first local infant formula production license and products available in over 1,500 supermarkets, diversifying revenue streams and mitigating market risks [9] Social Responsibility and Future Outlook - Feihe's commitment to social responsibility is evident in its 1.2 billion fertility subsidy plan, expected to benefit over 800,000 newborn families, aligning corporate strategy with market investment for future user growth [9] - The synergy between the buyback and dividend plans and the "new generation more suitable" strategy creates a robust cycle of financial strength supporting ongoing research and innovation, ensuring sustained cash flow and profit growth [9][10]

Market Performance - The Hong Kong and A-share markets saw a significant rise in baby and child-related stocks, particularly in the dairy sector, with several companies hitting their daily limit up [1] - In A-shares, companies such as Huangshi Group, Junyao Health, Nanjiao Food, and Sunshine Dairy reached their daily limit, while Knight Dairy rose over 8% [1] - In Hong Kong stocks, Youran Dairy increased by over 7%, Modern Dairy by over 3%, and Mengniu Dairy by 1% [1][3] Policy Impact - The recent surge in the market is attributed to a major signal released during the National Medical Security Work Conference on December 13, which stated the goal of achieving "no out-of-pocket" expenses for childbirth within the policy scope by 2026 [3] - The government is actively implementing a series of supportive policies for childbirth, including extended maternity leave, childcare subsidies, and educational housing support, to create a more favorable environment for childbirth [4] - The implementation of a national childcare subsidy system is set to begin on January 1, 2025, providing annual subsidies of 3,600 yuan per child under three years old [4][5] Demographic Trends - The national birth population is projected to reach 9.54 million in 2024, marking the first increase since 2017, although the overall population continues to decline [8] - The birth population for 2025 is expected to range between 7 million and 8.71 million, potentially hitting a record low since 1950 [8] - The central government's focus on stabilizing the birth population indicates a commitment to enhancing fertility policies, which may lead to increased demand in the maternal and infant sectors [6][8] Industry Outlook - The new policies are expected to directly benefit sectors such as assisted reproduction and obstetric healthcare, while also providing sustained advantages to the maternal and infant consumption industry chain, including retail, food, and supplies [8] - Analysts suggest that the government's financial support and the anticipated increase in newborns will boost consumer confidence and improve demand for infant formula products [8]